AMAIKE Trademark

Trademark Overview


On Friday, July 7, 2023, a trademark application was filed for AMAIKE with the United States Patent and Trademark Office. The USPTO has given the AMAIKE trademark a serial number of 79375964. The federal status of this trademark filing is REGISTERED as of Tuesday, May 28, 2024. This trademark is owned by Klinge Biopharma GmbH. The AMAIKE trademark is filed in the Pharmaceutical Products category with the following description:

Medicines and pharmaceutical preparations for human medical use, other than for dermatological purposes, in particular ophthalmological preparations for the treatment of eye diseases and ailments; medical plasters, other than for cosmetic purposes, and medical dressing materials and disinfectants, other than for dermatological purposes and for the skin

General Information


Serial Number79375964
Word MarkAMAIKE
Filing DateFriday, July 7, 2023
Status700 - REGISTERED
Status DateTuesday, May 28, 2024
Registration Number7394419
Registration DateTuesday, May 28, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2024

Trademark Statements


Goods and ServicesMedicines and pharmaceutical preparations for human medical use, other than for dermatological purposes, in particular ophthalmological preparations for the treatment of eye diseases and ailments; medical plasters, other than for cosmetic purposes, and medical dressing materials and disinfectants, other than for dermatological purposes and for the skin

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 14, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKlinge Biopharma GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE

Party NameKlinge Biopharma GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE

Party NameKlinge Biopharma GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events


Event DateEvent Description
Thursday, August 10, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, August 14, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 18, 2023APPLICATION FILING RECEIPT MAILED
Wednesday, September 13, 2023ASSIGNED TO EXAMINER
Thursday, September 14, 2023NON-FINAL ACTION WRITTEN
Friday, September 15, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, October 9, 2023REFUSAL PROCESSED BY MPU
Monday, October 9, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, November 1, 2023REFUSAL PROCESSED BY IB
Saturday, January 27, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, January 27, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, January 27, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 7, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 21, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 21, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, March 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 12, 2024NOTIFICATION PROCESSED BY IB
Tuesday, March 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sunday, May 26, 2024NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, May 28, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, May 28, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, August 29, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, November 14, 2024FINAL DISPOSITION PROCESSED
Friday, November 15, 2024FINAL DISPOSITION NOTICE SENT TO IB